Selskabets formål er at drive virksomhed inden for udvikling og fremstilling af samt handel med biomolekyler til den farmaceutiske industri og ernæringsindustrien.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | - | 1.5 mio. | 669.9 mio. | 508.5 mio. | 108 | |
CVR: 37207713
1 properties
Upgrade to Pro to see addresses, building data and ownership details
PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB appointed as auditor
KPMG P/S resigned as auditor
Companies in the same industry and area
Compared to 24 companies in Fremstilling af farmaceutiske råvarer
Comparison is based on industry median values
companydata.dk